Acquiring Company
Tempus AI
Acquired Company
Paige
ChicagoNew YorkBiotechnologySoftwareDescription
Tempus has announced the acquisition of Paige for $81.25 million, primarily in Tempus common stock. This acquisition enhances Tempus's capabilities in digital pathology and expands its dataset significantly. Paige brings a proven technology portfolio and strong expertise in AI applications for cancer detection. The merger is expected to accelerate Tempus's efforts in precision medicine.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed